Sai Katsunari, Yang Dongqin, Yamamoto Hideyuki, Fujikawa Hirokazu, Yamamoto Satoshi, Nagata Tetsu, Saito Masaru, Yamamura Takehira, Nishizaki Tomoyuki
Department of Physiology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan.
Neurotoxicology. 2006 Jul;27(4):458-67. doi: 10.1016/j.neuro.2005.12.008. Epub 2006 Feb 15.
Extracellular adenosine reduced viability of RCR-1 rat astrocytoma cells in a dose (0.3-10mM)- and treatment time (24-72h)-dependent manner. In the apoptosis assay using propidium iodide (PI) and annexin V, treatment with adenosine (1mM) for 72h increased the population of PI-negative/annexin V-positive cells, that is related to early apoptosis, and that of PI-positive/annexin V-positive cells, that is related to late apoptosis/secondary necrosis. In addition, nuclei of cells treated with adenosine (1mM) for 72h were reactive to an antibody against single-stranded DNA. Adenosine activated caspase-3, -8 and -9, but mitochondrial membrane potentials were not affected. Adenosine-induced RCR-1 cell death was significantly inhibited by 8-CPT, an antagonist of A(1) adenosine receptors, and forskolin, an adenylate cyclase activator. SQ22536, an adenylate cyclase inhibitor, alternatively, exhibited an effect similar to adenosine. CHA, an agonist of A(1) adenosine receptors, activated caspase-3 and -9, but not caspase-8. Adenosine-induced cytotoxicity of RCR-1 cells was also significantly inhibited by dipyridamole, an inhibitor of adenosine transporter, and AMDA, an inhibitor of adenosine kinase. AICAR, an activator of AMP-activated protein kinase (AMPK), reduced RCR-1 cell viability, but synergistic effect was not obtained with co-treatment with adenosine and AICAR. AICAR activated caspase-3 and -9, but not caspase-8. An additive inhibition was found in the co-presence of 8-CPT and dipyridamole. Extracellular adenosine, thus, appears to activate caspase-9 followed by the effector caspase, caspase-3, at least via two independent pathways linked to A(1) adenosine receptor-mediated adenylate cyclase inhibition and adenosine uptake into cells/conversion to AMP/activation of AMPK, possibly regardless of mitochondrial damage, thereby leading to RCR-1 cell death, dominantly by apoptosis. Moreover, caspase-8 activation could again contribute to adenosine-induced cytotoxicity, although the underlying mechanism is currently unknown. Collectively, the results of the present study may represent a new pathway for caspase activation relevant to diverse adenosine signals in cell death.
细胞外腺苷以剂量(0.3 - 10 mM)和处理时间(24 - 72小时)依赖的方式降低了RCR - 1大鼠星形细胞瘤细胞的活力。在使用碘化丙啶(PI)和膜联蛋白V的凋亡检测中,用腺苷(1 mM)处理72小时增加了PI阴性/膜联蛋白V阳性细胞群体(与早期凋亡相关)以及PI阳性/膜联蛋白V阳性细胞群体(与晚期凋亡/继发性坏死相关)。此外,用腺苷(1 mM)处理72小时的细胞的细胞核对单链DNA抗体有反应。腺苷激活了半胱天冬酶 - 3、 - 8和 - 9,但线粒体膜电位未受影响。腺苷诱导的RCR - 1细胞死亡被A(1)腺苷受体拮抗剂8 - CPT和腺苷酸环化酶激活剂福斯可林显著抑制。相反,腺苷酸环化酶抑制剂SQ22536表现出与腺苷类似的作用。A(1)腺苷受体激动剂CHA激活了半胱天冬酶 - 3和 - 9,但未激活半胱天冬酶 - 8。腺苷转运体抑制剂双嘧达莫和腺苷激酶抑制剂AMDA也显著抑制了腺苷诱导的RCR - 1细胞毒性。AMP激活蛋白激酶(AMPK)激活剂AICAR降低了RCR - 1细胞活力,但腺苷与AICAR共同处理未获得协同效应。AICAR激活了半胱天冬酶 - 3和 - 9,但未激活半胱天冬酶 - 8。在8 - CPT和双嘧达莫共同存在时发现了相加抑制作用。因此,细胞外腺苷似乎至少通过两条独立途径激活半胱天冬酶 - 9,随后激活效应半胱天冬酶 - 3,这两条途径与A(1)腺苷受体介导的腺苷酸环化酶抑制以及腺苷摄取到细胞中/转化为AMP/激活AMPK有关,可能与线粒体损伤无关,从而导致RCR - 1细胞死亡,主要通过凋亡。此外,半胱天冬酶 - 8激活可能再次导致腺苷诱导的细胞毒性,尽管其潜在机制目前尚不清楚。总体而言,本研究结果可能代表了一种与细胞死亡中多种腺苷信号相关的半胱天冬酶激活新途径。